The Therapeutic Effect of Thalidomide in Syringomyelia
NCT06268093
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Syringomyelia
Thalidomide
Interventions
DRUG:
Thalidomide
Sponsor
Xuanwu Hospital, Beijing